Sources | Names Used |
---|---|
CTRPv2 | navitoclax:birinapant (1:1 mol/mol) |
PharmacoGx | navitoclax:birinapant (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LINC00694 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
mRNA | KDM2B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
mRNA | HIRIP3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
mRNA | NBPF20 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
mRNA | ZNF792 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
mRNA | PRMT8 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
mRNA | SERPINH1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
mRNA | FRS2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
mRNA | UTS2B | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
mRNA | UGT2A2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |